rs200128474
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2
The NM_020451.3(SELENON):c.1654G>A(p.Glu552Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000344 in 1,614,184 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. E552E) has been classified as Likely benign.
Frequency
Consequence
NM_020451.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SELENON | NM_020451.3 | c.1654G>A | p.Glu552Lys | missense_variant | 13/13 | ENST00000361547.7 | |
SELENON | NM_206926.2 | c.1552G>A | p.Glu518Lys | missense_variant | 12/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SELENON | ENST00000361547.7 | c.1654G>A | p.Glu552Lys | missense_variant | 13/13 | 1 | NM_020451.3 | ||
SELENON | ENST00000374315.1 | c.1552G>A | p.Glu518Lys | missense_variant | 12/12 | 5 | P1 | ||
SELENON | ENST00000354177.9 | c.1483G>A | p.Glu495Lys | missense_variant | 12/12 | 5 | |||
SELENON | ENST00000494537.2 | c.*174G>A | 3_prime_UTR_variant, NMD_transcript_variant | 13/13 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000388 AC: 59AN: 152192Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000377 AC: 94AN: 249566Hom.: 0 AF XY: 0.000451 AC XY: 61AN XY: 135398
GnomAD4 exome AF: 0.000340 AC: 497AN: 1461874Hom.: 4 Cov.: 31 AF XY: 0.000358 AC XY: 260AN XY: 727242
GnomAD4 genome AF: 0.000381 AC: 58AN: 152310Hom.: 0 Cov.: 33 AF XY: 0.000457 AC XY: 34AN XY: 74472
ClinVar
Submissions by phenotype
not provided Uncertain:4Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 02, 2021 | This variant is associated with the following publications: (PMID: 20623375) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 18, 2013 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Dec 30, 2019 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Nov 12, 2021 | - - |
Eichsfeld type congenital muscular dystrophy Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | May 23, 2022 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Oct 16, 2023 | Variant summary: SELENON c.1654G>A (p.Glu552Lys) results in a conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00038 in 249566 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in SELENON causing Eichsfeld Type Congenital Muscular Dystrophy (0.00038 vs 0.0011), allowing no conclusion about variant significance. To our knowledge, no occurrence of c.1654G>A in individuals affected with Eichsfeld Type Congenital Muscular Dystrophy and no experimental evidence demonstrating its impact on protein function have been reported. Seven submitters have cited clinical-significance assessments for this variant to ClinVar after 2014 and classified as VUS (n=2) and benign/likely benign (n=2). Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Congenital myopathy with fiber type disproportion Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Dec 13, 2019 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
SEPN1-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 28, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at